Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses
dc.contributor.author | Kendall, Emily A. | |
dc.contributor.author | Kamoga, Caleb | |
dc.contributor.author | Kitonsa, Peter J. | |
dc.contributor.author | Nalutaaya, Annet | |
dc.contributor.author | Katamba, Achilles | |
dc.contributor.author | Dowdy, David W. | |
dc.date.accessioned | 2025-03-18T14:05:05Z | |
dc.date.available | 2025-03-18T14:05:05Z | |
dc.date.issued | 2019-07-24 | |
dc.description.abstract | Clinical tuberculosis diagnosis and empiric treatment have traditionally been common among patients with negative bacteriologic test results. Increasing availability of rapid molecular diagnostic tests, including Xpert MTB/RIF and the new Xpert Ultra cartridge, may alter the role of empiric treatment. | |
dc.identifier.citation | Kendall, E. A., Kamoga, C., Kitonsa, P. J., Nalutaaya, A., Salvatore, P. P., Robsky, K., ... & Dowdy, D. W. (2019). Empiric treatment of pulmonary TB in the Xpert era: correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses. PLoS One, 14(7), e0220251. | |
dc.identifier.other | https://doi.org/10.1371/journal.pone.0220251 | |
dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/10124 | |
dc.language.iso | en | |
dc.publisher | PLoS One | |
dc.title | Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses | |
dc.type | Article |